Sung Kyung Uk, Roh Jeong A, Eoh Kyung Jin, Kim Eui Hyeok
Department of Obstetrics and Gynecology, National Health Insurance Service Ilsan Hospital, Goyang, Korea.
Obstet Gynecol Sci. 2017 Mar;60(2):154-162. doi: 10.5468/ogs.2017.60.2.154. Epub 2017 Mar 16.
To examine the first-trimester maternal serum placental growth factor (PlGF) and pregnancy-associated plasma protein A (PAPP-A) levels in pregnancies associated with pre-eclampsia (PE) or small-for-gestational-age (SGA) infants, and determine the predictive accuracy of PlGF and of PAPP-A for either PE or SGA infants.
This prospective, observational study included 175 pregnant women, and of these women, due to participant withdrawal or loss to follow-up, delivery data were collected from the medical records of 155 women, including 4 who had twin pregnancies. The women's maternal history was recorded, and the PlGF and PAPP-A levels at 11 to 13 gestational weeks were measured. During the second trimester, the maternal uterine artery's systolic/diastolic ratio was measured. Multiples of the median (MoM) of PlGF and PAPP-A were determined, and the associations of these values with the risk factors of SGA and PE were evaluated. Logistic regression analysis was used to determine whether PlGF and PAPP-A are useful markers for predicting SGA infants.
The PAPP-A MoM level was significantly lower in women with advanced maternal age, multipara women, and women with gestational diabetes than in their counterparts. The PlGF and PAPP-A MoM levels were higher in women with a twin pregnancy than in those with a singleton pregnancy. There was a significant relationship between the maternal serum PAPP-A MoM level in the first trimester and the uterine artery systolic/diastolic ratio in the second trimester. Results of logistic regression analysis showed that low PlGF and PAPP-A MoM levels were predictors of SGA infants (odds ratio, 0.143; 95% confidence interval, 0.025 to 0.806; odds ratio, 0.191; 95% confidence interval, 0.051 to 0.718, respectively).
PlGF and PAPP-A are potentially useful as first-trimester markers for SGA infants and some hypertensive disorders of pregnancy.
检测子痫前期(PE)或小于胎龄儿(SGA)妊娠孕妇孕早期血清胎盘生长因子(PlGF)和妊娠相关血浆蛋白A(PAPP-A)水平,并确定PlGF和PAPP-A对PE或SGA婴儿的预测准确性。
这项前瞻性观察性研究纳入了175名孕妇,其中,由于参与者退出或失访,从155名妇女的病历中收集了分娩数据,包括4名怀有双胎妊娠的妇女。记录了这些妇女的孕产史,并测量了孕11至13周时的PlGF和PAPP-A水平。在孕中期,测量孕妇子宫动脉的收缩/舒张比。确定了PlGF和PAPP-A的中位数倍数(MoM),并评估了这些值与SGA和PE危险因素的关联。采用逻辑回归分析确定PlGF和PAPP-A是否为预测SGA婴儿的有用标志物。
高龄孕妇、经产妇和妊娠期糖尿病孕妇的PAPP-A MoM水平显著低于相应对照组。双胎妊娠妇女的PlGF和PAPP-A MoM水平高于单胎妊娠妇女。孕早期孕妇血清PAPP-A MoM水平与孕中期子宫动脉收缩/舒张比之间存在显著关系。逻辑回归分析结果显示,低PlGF和PAPP-A MoM水平是SGA婴儿的预测指标(优势比分别为0.143;95%置信区间为0.025至0.806;优势比为0.191;95%置信区间为0.051至0.718)。
PlGF和PAPP-A作为孕早期SGA婴儿和某些妊娠高血压疾病的标志物可能有用。